Publications 2012

Chaumeil M-M, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Lévi A-C, Carlier P, Lebon V. J Cereb Blood Flow Metab. pH as a biomarker of neurodegeneration in Huntington’s disease: a translational rodent-human MRS study. 2012 Feb 29. doi: 10.1038/jcbfm.2012.15. [Epub ahead of print]

Cubo E, González M, del Puerto I, de Yébenes JG, Arconada O-F, Gabriel y Galán JM. European Huntington’s Disease Initiative Study Group. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington’s disease. Mov Disord, 2012, Mar;27(3):439-42. doi: 10.1002/mds.24062. Epub 2011 Dec 9.

Moroy A, Belliver F, Fénelon G. Olfactory reference syndrome: an unusual delusion in a patient with Parkinson’s disease. J Neuropsychiatry Clin Neurosci, 2012 Jun 1;24(3):10002.

Fénelon G, Goujon C, Gurruchaga J-M, Cesaro P, Jarraya B, Palfi S, Lefaucheur J-P. Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson’s disease. Parkinsonism Relat Disord, 2012, 18:213-4.

Hosseini H, Mandat T, Waubant E, Agid Y, Lubetzki C, Lyon-Caen O, Stankoff B, Jedynak P, Cesaro P, Palfi S, Nguyen JP. Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis. Neurosurgery, 2012, 70:66-9.

Jacquemot, C., Dupoux, E., Robotham & Bachoud-Lévi, A-C. Specificity in rehabilitation of speech production: a meta-analysis and a case study. Behav Neurol, 2012, Jan 1; 25(2):73-101

Lee J-M, Ramos E-M, Lee J-H, Gillis T, Mysore J-S, Hayden M-R, Warby S-C, Morrison P, Nance M, Ross C-A, Margolis R-L, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent R-J, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS; PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY study of the European Huntington’s Disease Network, Myers RH; HD-MAPS Study Group, Macdonald M-E, Gusella J-F; COHORT study of the HSG. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.Neurology. 2012 Mar 6; 78(10):690-5. Epub, 2012, Feb 8.

Quarrell O-W, Handley O, O’Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer G-B; European Huntington’s Disease Network. Discrepancies in reporting the CAG repeat lengths for Huntington’s disease. Eur J Hum Genet, 2012, Jan; 20(1): 20-6. doi: 10.1038/ejhg.2011.136. Epub 2011 Aug 3.

Ripollés, P., Marco-Pallarés, J., de Diego-Balaguer, R., Miró, J., Falip, M., Juncadella, M., Rubio, F., Rodríguez-Fornells, A. (2012). Analysis of automated methods for spatial normalization of lesioned brains. Neuroimage.2012,Jan 28;60(2):1296-1306

Sambin S, Teichmann M, de Diego-Balaguer R, Giavazzi M, Sportiche D, Schlenker P, Bachoud-Lévi A-C. The role of the striatum in sentence processing: Disentangling syntax from working memory in Huntington’s disease. Neuropsychologia, 2012, Sep;50(11):2625-35. Epub 2012 Jul 20.

Cleret de Langavant L, Trinkler I, Remy P, Thirioux B, McIntyre J, Berthoz A, Dupoux E, Bachoud-Lévi A-C. Viewing another person’s body as a target object: a behavioural and PET study of pointing. Neuropsychologia, 2012, Jul;50(8):1801-13. Epub 2012 May 1

Bayen E, Cleret de Langavant L, Fénelon G. Le syndrome d’Alice au pays des merveilles. Une aura migraineuse inhabituelle. Rev Neurol (Paris) 2012; 168 :457-459. [in French]

Fénelon G, Brandel J-P. La maladie de Parkinson de début tardif : différences et similitudes par rapport à celle des sujets plus jeunes ? Cah Année Gérontol 2012, in press DOI 10.1007/s12612-0268-8 [in French]

Soulas T, Sultan S, Gurruchaga J-M, Palfi S, Fénelon G. Changes in quality of life, burden and mood in spouses of Parkinson’s disease patients undergoing neurostimulation. Park Relat Disord 2012; 18:602-605print]. PMID: 22579967.